The Invisible Threat: Why Micronanoplastics are a Systemic Immune Problem Across All Organ Systems

Our review synthesizes evidence on how ubiquitous micronanoplastics (MNPs) impact the immune system across major organ systems. The hidden threat is clear: MNPs are not just pollutants, but systemic immune system disruptors.

Published in Earth & Environment and Immunology

The Invisible Threat: Why Micronanoplastics are a Systemic Immune Problem Across All Organ Systems
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

SpringerLink
SpringerLink SpringerLink

The Micronanoplastics-immune axis across organ systems: towards a research agenda - Discover Medicine

The ubiquitous presence of micronanoplastic (MNP) pollution raises significant concerns regarding its potential impact on human health. This review synthesizes current evidence on the detrimental effects mediated by the MNP–immune axis across various organ systems. We explore the primary routes of MNP entry into the human body – inhalation, ingestion, and dermal contact – and their subsequent cellular interactions, including uptake mechanisms and cytotoxicity. Furthermore, we examine the immunomodulatory effects of MNP exposure in key organ systems, including the nervous, endocrine, integumentary, reproductive, respiratory, skeletal, cardiovascular, and digestive systems in human, animal, and in vitro models. Our analysis highlights the capacity of MNPs to induce oxidative stress, trigger inflammation, and disrupt immune homeostasis, potentially contributing to a range of adverse health outcomes such as neuroinflammation, endocrine disruption, skin damage, reproductive dysfunction, respiratory illnesses, bone degradation, cardiovascular disease, and gut microbiota alterations. We also propose an algorithm to guide future research on the MNP–immune axis. Understanding the intricate interplay between MNP and the immune system across different organs is crucial for assessing the full spectrum of human health risks associated with microplastic pollution and for developing effective mitigation strategies.

The Spark: Why This Review Now?

Over the last few years, research has confirmed that we ingest and inhale thousands of micronanoplastic (MNP) particles daily. Yet, the scientific community often operates in silos—studies on pulmonary effects are disconnected from those on reproductive failure or neurotoxicity.

This fragmentation led us to a crucial question: Is there a common mechanism linking these disparate adverse outcomes? We realized the scientific landscape required a comprehensive synthesis that connected these isolated "islands" of data, defining MNPs as a systemic, immunity-driven health problem.

The Challenge: Mapping the Immune Highway

The task was colossal. We had to synthesize evidence from human, animal, and in vitro models, covering eight major body systems (nervous, endocrine, respiratory, digestive, and others).

The greatest challenge was reconciling the vast differences in MNP data—particles varied in shape, size, material, and concentration across studies. We needed to identify a universal language of toxicity that could explain why such diverse particles lead to such consistently alarming pathologies.

Our Key Finding: Inflammation is the Common Thread

Our analysis revealed that MNPs are not passive, inert particles; they are active disruptors of cellular processes. The core mechanism of their harm is a cascading immune dysfunction, primarily manifesting through two pathways:

  1. Oxidative Stress: MNPs induce excessive production of free radicals, damaging cells across all organs.

  2. Immune Dysregulation: The particles trigger persistent, low-grade inflammation that can contribute to neuroinflammation, endocrine disruption, and other chronic illnesses.

In essence, we found that the immune system acts as the highway through which MNPs exert their systemic effects across the entire body.

The Research Agenda: What Happens Next?

Our review is not an endpoint; it is a roadmap. It’s a clear call to action for the scientific community. To effectively combat this global threat, standardization is essential. We urge researchers to:

  1. Standardize Protocols: Adopt unified testing protocols and MNP characterization metrics to make results truly comparable globally.

  2. Focus on Nanoplastics: Increase research on the smallest fraction—nanoplastics—as their capacity to cross biological barriers (like the blood-brain and placental barriers) presents the most significant threat.

  3. Transition to Clinical Relevance: Develop clinical intervention and prevention strategies to protect human health from this pervasive environmental danger.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Immunology
Life Sciences > Biological Sciences > Immunology
Immunological Disorders
Life Sciences > Biological Sciences > Immunology > Immunological Disorders
Immunotoxicity
Life Sciences > Biological Sciences > Immunology > Immunotoxicity
Pollution
Physical Sciences > Earth and Environmental Sciences > Environmental Sciences > Pollution
Inflammatory diseases
Life Sciences > Biological Sciences > Immunology > Immunological Disorders > Inflammatory diseases
Autoimmunity
Life Sciences > Biological Sciences > Immunology > Autoimmunity

Ask the Editor - Immunology, Pathogenesis, Inflammation and Innate Immunity

Got a question for the editor about the complement system in health and disease? Ask it here!

Continue reading announcement

Related Collections

With Collections, you can get published faster and increase your visibility.

Gut Microbiome and Human Well Being

The human gut microbiome plays a critical role in maintaining health and modulating disease processes. Its composition evolves across the lifespan under the influence of diet, lifestyle, aging, and environmental exposures. Disruption of gut microbial balance—known as dysbiosis—has been implicated in the pathogenesis of various chronic conditions, including autoimmune, metabolic, neurological, and inflammatory diseases.

This Collection welcomes submissions that explore the mechanistic, clinical, and translational aspects of gut microbiota in human health, with particular interest in:

The gut–brain, gut–heart, gut–cancer, and gut–joint axes

Gut dysbiosis and its immunological and metabolic consequences

Microbial metabolites and host-microbiome interactions

Microbiome-based diagnostics, therapeutic interventions, and biomarkers

We invite contributions including but not limited to:

Original research articles based on clinical, in vivo or in vitro studies

Reviews summarizing recent advances or proposing new frameworks

Perspective or opinion pieces that highlight emerging concepts or challenges

This Collection aims to enhance our understanding of the gut microbiome's contribution to health and disease and to inspire microbiome-based strategies for improving human well-being.

Keywords: Gut microbiome; Gut-organ-axis; chronic diseases; 16S rRNA; metagenomics

Publishing Model: Open Access

Deadline: Jul 01, 2026

Advances in Cardiovascular Diagnostics, Interventional Therapies, and Arrhythmia Management

Cardiovascular diseases remain a major global health challenge worldwide, continuing to be a leading cause of morbidity and mortality despite substantial advances in prevention and treatment. In recent years, progress in cardiovascular diagnostics, interventional techniques, and arrhythmia management has significantly improved patient care; however, important challenges persist, including timely diagnosis, individualized risk stratification, optimization of interventional strategies, and long-term outcome improvement. These unmet needs highlight the necessity for continued innovation and multidisciplinary research efforts in cardiovascular medicine.

This Collection aims to highlight recent advances in cardiovascular diagnostics, interventional therapies, and arrhythmia management, with a focus on clinically relevant and translational research. We welcome submissions addressing interventional cardiology procedures, catheter ablation techniques, three-dimensional electroanatomical mapping, mechanisms of cardiac arrhythmias, cardiovascular imaging, acute coronary syndromes, and hypertension. Contributions that enhance understanding of disease mechanisms, improve procedural outcomes, or inform clinical decision-making are particularly encouraged.

By bringing together high-quality experimental, clinical, and translational studies, this Collection seeks to advance scientific knowledge, support the development of improved therapeutic strategies, and foster global collaboration in the field of cardiovascular medicine.

Keywords:

Cardiology; Arrhythmia; Ablation; 3D mapping; Interventional cardiology; Hypertension; Acute coronary syndrome; Cardiovascular imaging; COVID-19

Publishing Model: Open Access

Deadline: Oct 12, 2026